secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenon Pharmaceuticals Inc. (XENE)
CIK:        0001582313
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0000950170-23-026070
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Xenon Pharmaceuticals announces results of 2023 annual meeting; all proposals approved
--------------------------------------------------------------------------------

- All 8 director nominees elected; highest vote count 50.7M (Svoronos, Gannon), lowest 48.5M (Machado).
- Say-on-pay advisory vote approved: 44.2M for, 6.7M against, 3.3K abstain; 1.9M broker non-votes.
- KPMG appointed as auditor with 51.5M votes for, 1.3M withheld.
- Auditor remuneration authority approved: 50.7M for, 284K against, 2.8K abstain; 1.8M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582313/000095017023026070/0000950170-23-026070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582313/000095017023026070/xene-20230601.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-026070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer